Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity.
Marwa Monier Mahmoud RefaieAsmaa Ma BayoumiSahar Ahmed MokhemerSayed ShehataNahla Mohammed Abd El-HameedPublished in: Human & experimental toxicology (2023)
DAP could reduce CP cardiotoxicity based upon its ability to modulate SGLT2 and HIF1α/VEGF/eNOS signaling pathway.